{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:02:01Z","timestamp":1767337321855,"version":"3.40.5"},"reference-count":47,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"abstract":"<jats:p>Objective.We previously reported on children with opsoclonus-ataxia and found pervasive neurodevelopmental deficits, years after onset, without a clear relationship to treatment modality or timing of treatment. A significant negative correlation of functional status with age at testing raised a question of whether opsoclonus-ataxia is a progressive encephalopathy. We attempted to answer this question with serial testing. In addition, we examined the relationship between clinical course and developmental outcome.<\/jats:p><jats:p>Methods.Thirteen of 17 children with opsoclonus-ataxia, all with neuroblastoma, who were previously reported were reevaluated a second time 2 to 4 years after the initial assessment. One subject who lived out of state was partially reevaluated and is included. Five new subjects (2 with neuroblastoma and 3 without) were also enrolled. Each was evaluated twice at a minimum interval of 1 year between sessions. Intercurrent medical course was recorded, emphasizing medication and relapse history. Cognitive, adaptive behavior, academic, speech and language, and motor abilities were assessed.<\/jats:p><jats:p>Results.For the group as a whole, overall standardized, age-adjusted cognitive scores improved. Generally, younger subjects' cognitive and adaptive behavior scores improved more than older subjects. Although all subjects had gains in speech, language, and motor function, some progressed at a slow pace, and in some instances, standard scores dropped. There was a striking influence of clinical course. Although initial presentation was severe and all subjects required high doses of corticosteroids or corticotropin, 5 had a monophasic course and were able to be weaned from treatment without relapses. Fourteen had multiple relapses over the years, generally with reduction of medication or intercurrent illnesses. Of the 5 children with monophasic course, 4 are currently functioning in the average range with a full-scale IQ of \u226590 and age-appropriate academic and adaptive skills.<\/jats:p><jats:p>Conclusions.The results continue to raise concern that opsoclonus-ataxia is sometimes a progressive encephalopathy. A minority of children with opsoclonus-ataxia have a monophasic course. Despite initial severity of symptoms, these children may have a more benign prognosis. For the majority of children with opsoclonus-ataxia, the course includes multiple relapses and requires prolonged treatment. Developmental sequelae are significant in these children with chronic course.<\/jats:p>","DOI":"10.1542\/peds.2004-2377","type":"journal-article","created":{"date-parts":[[2005,9,30]],"date-time":"2005-09-30T18:42:55Z","timestamp":1128105775000},"page":"901-907","source":"Crossref","is-referenced-by-count":39,"title":["Longitudinal Neurodevelopmental Evaluation of Children With Opsoclonus-Ataxia"],"prefix":"10.1542","volume":"116","author":[{"given":"Wendy G.","family":"Mitchell","sequence":"first","affiliation":[{"name":"Division of Neurology"},{"name":"Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virdette L.","family":"Brumm","sequence":"additional","affiliation":[{"name":"Division of Neurology"},{"name":"Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen G.","family":"Azen","sequence":"additional","affiliation":[{"name":"General Clinical Research Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten E.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Physical and Occupational Therapy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia K.","family":"Aller","sequence":"additional","affiliation":[{"name":"University of Southern California University Affiliated Program at Childrens Hospital Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Division of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2005,10,1]]},"reference":[{"key":"2021120819491621900_R1","doi-asserted-by":"crossref","unstructured":"Brissaud HE, Beauvais P. Opsoclonus and neuroblastoma. N Engl J Med.\u20081969;280:1242","DOI":"10.1056\/NEJM196905292802218"},{"key":"2021120819491621900_R2","unstructured":"Bray PF, Ziter FA, Lahey ME, Myers GG. The coincidence of neuroblastoma and acute cerebellar encephalopathy. Trans Am Neurol Assoc.\u20081969;94:106\u2013109"},{"key":"2021120819491621900_R3","unstructured":"Boltshauser E, Deonna T, Hirt HR. Myoclonic encephalopathy of infants or \u201cdancing eyes syndrome.\u201d Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma). Helv Paediatr Acta.\u20081979;34:119\u2013133"},{"key":"2021120819491621900_R4","unstructured":"Blake J, Fitzpatrick C. Eye signs in neuroblastoma. Trans Ophthalmol Soc U K.\u20081972;92:825\u2013833"},{"key":"2021120819491621900_R5","doi-asserted-by":"crossref","unstructured":"Sandok BA, Kranz H. Opsoclonus as the initial manifestation of occult neuroblastoma. Arch Ophthalmol.\u20081971;86:235\u2013236","DOI":"10.1001\/archopht.1971.01000010237018"},{"key":"2021120819491621900_R6","doi-asserted-by":"crossref","unstructured":"Cao Y, Abbas J, Wu X, Dooley J, van Amburg AL. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature. Gynecol Oncol.\u20081999;75:178\u2013183","DOI":"10.1006\/gyno.1999.5553"},{"key":"2021120819491621900_R7","doi-asserted-by":"crossref","unstructured":"Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain.\u20081997;120:1279\u20131300","DOI":"10.1093\/brain\/120.8.1279"},{"key":"2021120819491621900_R8","doi-asserted-by":"crossref","unstructured":"Matsushita H, Kodama S, Aoki Y, Tanaka K, Saito N. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer. Gynecol Obstet Invest.\u20081998;45:140\u2013143","DOI":"10.1159\/000009942"},{"key":"2021120819491621900_R9","doi-asserted-by":"crossref","unstructured":"Connolly AM, Pestronk A, Mehta S, Pranzatelli MR 3rd, Noetzel MJ. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr.\u20081997;130:878\u2013884","DOI":"10.1016\/S0022-3476(97)70272-5"},{"key":"2021120819491621900_R10","doi-asserted-by":"crossref","unstructured":"Antunes NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol.\u20082000;22:315\u2013320","DOI":"10.1097\/00043426-200007000-00007"},{"key":"2021120819491621900_R11","unstructured":"Connolly AM, Mitchell WG, Pestronk A, et al. Serum IgM autoantibodies in patients with paraneoplastic and idiopathic opsoclonus myoclonus syndrome (OMS) recognize neurofilament and histone in neural preparations [abstract]. Ann Neurol.\u20081999;46:536\u2013537"},{"key":"2021120819491621900_R12","doi-asserted-by":"crossref","unstructured":"Fisher PG, Wechsler DS, Singer HS. Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Pediatr Neurol.\u20081994;10:309\u2013312","DOI":"10.1016\/0887-8994(94)90127-9"},{"key":"2021120819491621900_R13","doi-asserted-by":"crossref","unstructured":"Salmaggi A, Nemni R, Pozzi A, et al. Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report. Tumori.\u20081997;83:709\u2013711","DOI":"10.1177\/030089169708300316"},{"key":"2021120819491621900_R14","doi-asserted-by":"crossref","unstructured":"Hammer MS, Larsen MB, Stack CV. Outcome of children with opsoclonus-myoclonus regardless of etiology. Pediatr Neurol.\u20081995;13:21\u201324","DOI":"10.1016\/0887-8994(95)00083-R"},{"key":"2021120819491621900_R15","doi-asserted-by":"crossref","unstructured":"Petruzzi MJ, de Alarcon PA. Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G. J Pediatr.\u20081995;127:328\u2013329","DOI":"10.1016\/S0022-3476(95)70322-5"},{"key":"2021120819491621900_R16","doi-asserted-by":"crossref","unstructured":"Pless M, Ronthal M. Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin. Neurology.\u20081996;46:583\u2013584","DOI":"10.1212\/WNL.46.2.583-a"},{"key":"2021120819491621900_R17","doi-asserted-by":"crossref","unstructured":"Sugie H, Sugie Y, Akimoto H, Endo K, Shirai M, Ito M. High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome. Acta Paediatr.\u20081992;81:371\u2013372","DOI":"10.1111\/j.1651-2227.1992.tb12248.x"},{"key":"2021120819491621900_R18","doi-asserted-by":"crossref","unstructured":"Veneselli E, Conte M, Biancheri R, Acquaviva A, De Bernardi B. Effect of steroid and high-dose immunoglobulin therapy on opsoclonus- myoclonus syndrome occurring in neuroblastoma. Med Pediatr Oncol.\u20081998;30:15\u201317","DOI":"10.1002\/(SICI)1096-911X(199801)30:1<15::AID-MPO6>3.0.CO;2-3"},{"key":"2021120819491621900_R19","doi-asserted-by":"crossref","unstructured":"Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol.\u20081997;28:284\u2013288","DOI":"10.1002\/(SICI)1096-911X(199704)28:4<284::AID-MPO7>3.0.CO;2-E"},{"key":"2021120819491621900_R20","doi-asserted-by":"crossref","unstructured":"Rudnick E, Khakoo Y, Antunes NL, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies\u2014a report from the Children's Cancer Group Study. Med Pediatr Oncol.\u20082001;36:612\u2013622","DOI":"10.1002\/mpo.1138"},{"key":"2021120819491621900_R21","doi-asserted-by":"crossref","unstructured":"Mitchell WG, Davalos-Gonzalez Y, Brumm VL, et al. Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics.\u20082002;109:86\u201398","DOI":"10.1542\/peds.109.1.86"},{"key":"2021120819491621900_R22","doi-asserted-by":"crossref","unstructured":"Koh PS, Raffensperger JG, Berry S, et al. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr.\u20081994;125:712\u2013716","DOI":"10.1016\/S0022-3476(06)80167-8"},{"key":"2021120819491621900_R23","doi-asserted-by":"crossref","unstructured":"Mitchell WG, Snodgrass RS. Opsoclonus\/ataxia in childhood neural crest tumors: a chronic neurologic syndrome. J Child Neurol.\u20081990;5:153\u2013158","DOI":"10.1177\/088307389000500217"},{"key":"2021120819491621900_R24","doi-asserted-by":"crossref","unstructured":"Papero PH, Pranzatelli MR, Margolis LJ, Tate E, Wilson LA, Glass P. Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome. Dev Med Child Neurol.\u20081995;37:915\u2013932","DOI":"10.1111\/j.1469-8749.1995.tb11944.x"},{"key":"2021120819491621900_R25","doi-asserted-by":"crossref","unstructured":"Pohl KR, Pritchard J, Wilson J. Neurological sequelae of the dancing eye syndrome. Eur J Pediatr.\u20081996;155:237\u2013244","DOI":"10.1007\/BF01953945"},{"key":"2021120819491621900_R26","doi-asserted-by":"crossref","unstructured":"Telander RL, Smithson WA, Groover RV. Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma. J Pediatr Surg.\u20081989;24:11\u201314","DOI":"10.1016\/S0022-3468(89)80291-X"},{"key":"2021120819491621900_R27","unstructured":"Sparrow S, Balla D, Cicchetti D. Vineland Adaptive Behavior Scales. Circle Pines, MN: American Guidance Service; 1984"},{"key":"2021120819491621900_R28","doi-asserted-by":"crossref","unstructured":"Wechsler D. Wechsler Preschool and Primary Scale of Intelligence. Revised ed. San Antonio, TX: Psychological Corporation; 1989","DOI":"10.1037\/t48859-000"},{"key":"2021120819491621900_R29","unstructured":"Wechsler D. Wechsler Intelligence Scales for Children. 3rd ed. San Antonio, TX: Psychological Corporation; 1991"},{"key":"2021120819491621900_R30","unstructured":"Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: Psychological Corporation; 1993"},{"key":"2021120819491621900_R31","unstructured":"Wilkinson GS. Wide Range Achievement Test-3 Administration Manual. Wilmington, DE: Wide Range, Inc; 1993"},{"key":"2021120819491621900_R32","unstructured":"Woodcock R, Johnson M. Woodcock Johnson Tests of Achievement-Revised. Itasca, IL: Riverside Publishing Company; 1989"},{"key":"2021120819491621900_R33","unstructured":"Beery KE. Beery-Buktenica Developmental Test of Visual-Motor Integration. 4th edition, Revised. Parsippany, NJ: Modern Curriculum Press; 1997"},{"key":"2021120819491621900_R34","unstructured":"Folio MR, Fewell RR. Peabody Developmental Motor Scales. Itasca, IL: Riverside Publishing Company; 2000"},{"key":"2021120819491621900_R35","doi-asserted-by":"crossref","unstructured":"Duger T, Bumin G, Uyanik M, Aki E, Kayihan H. The assessment of Bruininks-Oseretsky test of motor proficiency in children. Pediatr Rehabil.\u20081999;3:125\u2013131","DOI":"10.1080\/136384999289531"},{"key":"2021120819491621900_R36","unstructured":"Achenbach TM, Edelbrock CS. Child Behavior Checklist. Burlington, VT: University of Vermont, Department of Psychiatry; 1986"},{"key":"2021120819491621900_R37","doi-asserted-by":"crossref","unstructured":"Dunn LM, Dunn LM. Peabody Picture Vocabulary Test. 3rd ed. Circle Pines, MN: American Guidance Service, Inc; 1997","DOI":"10.1037\/t15145-000"},{"key":"2021120819491621900_R38","unstructured":"Williams K. Expressive Vocabulary Test. Circle Pines, MN: American Guidance Service, Inc; 1997"},{"key":"2021120819491621900_R39","unstructured":"Gardner M. Expressive One-Word Picture Vocabulary Test-Revised. Novato, CA: Academic Therapy Publications, Inc; 1990"},{"key":"2021120819491621900_R40","unstructured":"Newcomer PL, Hammill DD. Test of Language Development-Primary. 3rd ed. Austin, TX: PRO-ED, Inc; 1997"},{"key":"2021120819491621900_R41","unstructured":"Hammill DD, Newcomer PL. Test of Language Development-Intermediate. 3rd ed. Austin, TX: PRO-ED, Inc; 1997"},{"key":"2021120819491621900_R42","unstructured":"Zimmerman I, Steiner V, Pond R. The Preschool Language Scale. 3rd ed. San Antonio, TX: Psychological Corporation; 1992"},{"key":"2021120819491621900_R43","unstructured":"Semel E, Wiig E, Secord W. Clinical Evaluation of Language Fundamentals. 3rd ed. San Antonio, TX: Psychological Corporation; 1995"},{"key":"2021120819491621900_R44","unstructured":"Miller JF. Assessing Language Production in Children. Baltimore, MD: University Park Press; 1981"},{"key":"2021120819491621900_R45","unstructured":"Brown R. A First Language. Cambridge, MA: Harvard University Press; 1973"},{"key":"2021120819491621900_R46","unstructured":"Goldman R, Fristoe M. Goldman Fristoe Test of Articulation. Circle Pines, MN: American Guidance Service, Inc; 1986"},{"key":"2021120819491621900_R47","doi-asserted-by":"crossref","unstructured":"Pranzatelli MR, Travelstead AL, Tate ED, et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology.\u20082004;62:1526\u20131532","DOI":"10.1212\/WNL.62.9.1526"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/4\/901\/1024212\/zpe01005000901.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/116\/4\/901\/1024212\/zpe01005000901.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T21:25:31Z","timestamp":1683235531000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/116\/4\/901\/68072\/Longitudinal-Neurodevelopmental-Evaluation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,10,1]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2004-2377","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}